Shared on10 Oct 25Fair value Increased 5.81%
Narrative Update: Curaleaf Holdings Analyst Price Target Analysts have raised Curaleaf Holdings' fair value estimate from $3.83 to $4.06, citing increased expectations for regulatory progress and Curaleaf's ongoing brand strength in the cannabis sector. Analyst Commentary Bullish Takeaways Bullish analysts see regulatory progress as a key catalyst that could enhance Curaleaf's valuation in the near term.
Shared on04 Sep 25
Despite steady revenue growth forecasts, Curaleaf Holdings' future P/E multiple has increased markedly, signaling a higher valuation relative to earnings and maintaining the consensus analyst price target at CA$3.83. Valuation Changes Summary of Valuation Changes for Curaleaf Holdings The Consensus Analyst Price Target remained effectively unchanged, at CA$3.83.
Shared on24 Apr 25Fair value Decreased 0.47%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on17 Apr 25Fair value Increased 3.12%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on09 Apr 25Fair value Decreased 1.88%
AnalystConsensusTarget has increased discount rate from 6.3% to 7.2%.
Shared on02 Apr 25Fair value Increased 9.67%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.